LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Détails
ID Serval
serval:BIB_AA7296087B5B
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
LBA32 Principal results of the EORTC-1508 trial: A phase II randomised, multicentre study of bevacizumab vs atezolizumab and bevacizumab with acetylsalicylic acid or placebo in recurrent platinum-resistant ovarian, fallopian tube or primary peritoneal adenocarcinoma
Périodique
Annals of Oncology
ISSN
0923-7534
Statut éditorial
Publié
Date de publication
09/2021
Volume
32
Pages
S1308
Langue
anglais
Mots-clé
Oncology, Hematology
Web of science
Open Access
Oui
Création de la notice
12/01/2022 11:26
Dernière modification de la notice
13/01/2022 7:33